|
| 37878787 | The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review. | Oncologist | 2024 |
| 37878787 | The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review. | Oncologist | 2024 |
| 37345354 | NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol. | Pediatr Blood Cancer | 2023 |
| 37966258 | Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. | Cancer Res Commun | 2023 |
| 37347686 | The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor. | Pediatr Blood Cancer | 2023 |
| 37345354 | NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol. | Pediatr Blood Cancer | 2023 |
| 37966258 | Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. | Cancer Res Commun | 2023 |
| 37347686 | The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor. | Pediatr Blood Cancer | 2023 |
| 36387865 | Pediatric adrenocortical carcinoma. | Front Endocrinol (Lausanne) | 2022 |
| 35511749 | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Mol Cancer Ther | 2022 |
| 35740680 | Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid Tumors. | Cancers (Basel) | 2022 |
| 36387865 | Pediatric adrenocortical carcinoma. | Front Endocrinol (Lausanne) | 2022 |
| 35740680 | Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid Tumors. | Cancers (Basel) | 2022 |
| 35511749 | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Mol Cancer Ther | 2022 |
| 34304884 | Editorial: Special issue on rare cancers. | Curr Probl Cancer | 2021 |
| 33615670 | Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET. | Am J Med Genet A | 2021 |
| 34304884 | Editorial: Special issue on rare cancers. | Curr Probl Cancer | 2021 |
| 34898541 | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma. | Curr Oncol | 2021 |
| 34428097 | Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. | JCO Clin Cancer Inform | 2021 |
| 33615670 | Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET. | Am J Med Genet A | 2021 |
| 34898541 | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma. | Curr Oncol | 2021 |
| 34428097 | Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. | JCO Clin Cancer Inform | 2021 |
| 33020472 | Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. | Nat Commun | 2020 |
| 31917677 | Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma. | Endocrinol Diabetes Metab Case Rep | 2020 |
| 33020472 | Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. | Nat Commun | 2020 |
| 31917677 | Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma. | Endocrinol Diabetes Metab Case Rep | 2020 |
| 30908866 | From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. | Am J Med Genet A | 2019 |
| 30908866 | From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. | Am J Med Genet A | 2019 |
| 28001089 | The role of the immune system in neurofibromatosis type 1-associated nervous system tumors. | CNS Oncol | 2017 |
| 28551330 | Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. | Hum Pathol | 2017 |
| 28592921 | Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. | Sarcoma | 2017 |
| 29117388 | Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. | J Natl Cancer Inst | 2017 |
| 28001089 | The role of the immune system in neurofibromatosis type 1-associated nervous system tumors. | CNS Oncol | 2017 |
| 29117388 | Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. | J Natl Cancer Inst | 2017 |
| 28592921 | Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. | Sarcoma | 2017 |
| 28551330 | Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. | Hum Pathol | 2017 |
| 26933241 | Controlling Genetic Background in Crosses of Mouse Models of Cancer. | Cold Spring Harb Protoc | 2016 |
| 32765971 | Developing therapies for rare tumors: opportunities, challenges and progress. | Expert Opin Orphan Drugs | 2016 |
| 27155140 | The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. | Am J Med Genet A | 2016 |
| 26933251 | The Effects of Genetic Background of Mouse Models of Cancer: Friend or Foe? | Cold Spring Harb Protoc | 2016 |
| 26933242 | Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes. | Cold Spring Harb Protoc | 2016 |
| 26933241 | Controlling Genetic Background in Crosses of Mouse Models of Cancer. | Cold Spring Harb Protoc | 2016 |
| 26962017 | M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma. | Neuro Oncol | 2016 |
| 32765971 | Developing therapies for rare tumors: opportunities, challenges and progress. | Expert Opin Orphan Drugs | 2016 |
| 27155140 | The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. | Am J Med Genet A | 2016 |
| 26962017 | M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma. | Neuro Oncol | 2016 |
| 26933251 | The Effects of Genetic Background of Mouse Models of Cancer: Friend or Foe? | Cold Spring Harb Protoc | 2016 |
| 26933242 | Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes. | Cold Spring Harb Protoc | 2016 |
| 25381154 | The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients. | Cancer Res | 2015 |
| 25925892 | Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma. | Clin Cancer Res | 2015 |